In breast cancer cells, the decrease in CXCL13 leads to the decreased expression of CXCR5, p-ERK/ERK, and cyclin D1 as well as the increased expression of cleaved Casp-9, which is an initiator caspase protease for apoptosis [104]. Here, CXCL13 is linked to breast carcinoma.